Home > PS Ratio > LASA SUPERGENERICS

LASA SUPERGENERICS
PS (Price/Sales) Ratio

The Current P/S Ratio of LASA SUPERGENERICS is 1.05.

Share Price ₹24.5Apr 19,2024
Market Cap ₹122.9 Cr
Sales-TTM₹116.8 CrTTM-Standalone Results
Price/Sales1.05xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for LASA SUPERGENERICS
Please provide your vote to see the results
LASA SUPERGENERICS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of LASA SUPERGENERICS

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of LASA SUPERGENERICS is calculated as :

Current Market Cap [ ₹122.9 Cr] as on Apr 19,2024

(/) Sales [ ₹116.8 Cr] based on TTM-Standalone Results

(=) P/S Ratio [ 1.05x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for LASA SUPERGENERICS , the investors are currently willing to pay '1.05 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of LASA SUPERGENERICS !

The chart below summarizes the trend in P/S Ratio of LASA SUPERGENERICS over the last five years.

Historical PS (Price/Sales) ratio chart of LASA SUPERGENERICS


PS Ratio Performance Analysis for LASA SUPERGENERICS

- LASA SUPERGENERICS 's latest p/e ratio is 1.05x.

- LASA SUPERGENERICS 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 0.89x.

- LASA SUPERGENERICS 's operated at median p/e ratio of 0.71x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, LASA SUPERGENERICS 's p/e ratio peaked in Mar2022 at 1.52x.

- LASA SUPERGENERICS 's p/e ratio hit its five-year low in Mar2019 of 0.31x.


How does LASA SUPERGENERICS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
LASA SUPERGENERICS 116.81.05122.9
SUN PHARMACEUTICAL INDUSTRIES LTD47,444.67.70365,311.0
CIPLA LTD25,350.24.28108,623.0
DR REDDYS LABORATORIES LTD27,212.53.6499,134.3
ZYDUS LIFESCIENCES LTD19,024.24.8892,794.9
DIVIS LABORATORIES LTD7,492.813.0097,408.4
MANKIND PHARMA LTD9,946.39.4193,565.4
TORRENT PHARMACEUTICALS LTD10,474.08.2085,858.5
LUPIN LTD19,480.13.6270,506.8
AUROBINDO PHARMA LTD27,894.72.2863,697.4
ABBOTT INDIA LTD5,753.49.6555,528.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs LASA SUPERGENERICS 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 1.05x
Max industry PS 13.00x
Median industry PS 4.88x
Average industry PS 6.16x



You may also like the below Video Courses